Prime Medicine: Pay

Prime Medicine paid its 4 named executives $9.0M in total in FY2025 (Dec). CEO Allan Reine, M.D. was paid $3.9M of that.

Pay$100 in the stock at the end of FY24 → $119
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Allan Reine, M.D.Chief Executive Officer
FY2025 (Dec)
1 year
Keith GottesdienerFormer Chief Executive Officer
FY2025 (Dec)
1 year
FY2025 (Dec)
FY2023 (Dec)
FY2022 (Dec)Low confidence
3 years
Jeremy Duffield, M.D., Ph.D., FRCPFormer Chief Scientific Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Low confidence
4 years

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.